First Horizon to Pay SEC Fine Over Broker Rule Compliance
By Dean Seal
First Horizon has agreed to pay regulators a $325,000 fine to resolve claims that its practice for ensuring compliance with brokers' "best interest" standard wasn't up to snuff until last year.
The U.S. Securities and Exchange Commission alleged Wednesday that from July 2020, when the agency started implementing the so-called Regulation Best Interest, until February 2023, First Horizon reviewed structured note transaction recommendations for compliance with the broker rule after those transactions had been executed.
The Memphis-based financial services company filed and cleared exception reports for noncompliant transactions, but based on its scheduling protocols, many exceptions weren't cleared until after the transactions were executed, the SEC said.
First Horizon changed its policy in February of last year and now approves structured note recommendations before transactions are executed, according to the agency.
The SEC further accuses First Horizon of initially failing to enforce Regulation Best Interest for customer accounts that it acquired in a tie-up with Iberia Financial Services in 2020.
Without admitting or denying the SEC's findings, First Horizon agreed to resolve the matter with a civil fine.
The SEC finalized Regulation Best Interest in 2020, hoping to toughen up the fiduciary standard imposed on brokers by requiring them to consider alternatives to the products or strategies they recommend, with the goal of serving the client's best interest.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
September 18, 2024 10:15 ET (14:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks